Arjun Agarwal

CIK: 0002033974

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)30 (68.2%)

Position reduction

Option Exercises (M)12 (27.3%)

Derivative conversions

Awards (A)2 (4.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ORKA

Oruka Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (44 total)

ORKA
Oruka Therapeutics, Inc.
Oct 12, 2026
Exercise(M)
Direct
8.5K shares at avg. $12.50$107K
ORKA
Oruka Therapeutics, Inc.
Oct 12, 2026
Exercise(M)
Direct
1.5K shares at avg. $34.39$50K
ORKA
Oruka Therapeutics, Inc.
Oct 12, 2026
Sale(S)
Direct
5.7K shares at avg. $80.03$459K
ORKA
Oruka Therapeutics, Inc.
Oct 12, 2026
Sale(S)
Direct
2.1K shares at avg. $80.76$170K
ORKA
Oruka Therapeutics, Inc.
Oct 12, 2026
Sale(S)
Direct
2K shares at avg. $81.86$160K
ORKA
Oruka Therapeutics, Inc.
Oct 12, 2026
Sale(S)
Direct
200 shares at avg. $82.83$17K
ORKA
Oruka Therapeutics, Inc.
Sep 21, 2026
Sale(S)
Direct
533 shares at avg. $95.75$51K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
560 shares at avg. $95.71$54K
ORKA
Oruka Therapeutics, Inc.
Sep 11, 2026
Sale(S)
Direct
200 shares at avg. $94.02$19K
ORKA
Oruka Therapeutics, Inc.
Sep 11, 2026
Sale(S)
Direct
2.2K shares at avg. $93.26$206K
ORKA
Oruka Therapeutics, Inc.
Sep 11, 2026
Sale(S)
Direct
4.1K shares at avg. $92.41$374K
ORKA
Oruka Therapeutics, Inc.
Sep 11, 2026
Sale(S)
Direct
3K shares at avg. $91.11$273K
ORKA
Oruka Therapeutics, Inc.
Sep 11, 2026
Exercise(M)
Direct
1.5K shares at avg. $34.39$50K
ORKA
Oruka Therapeutics, Inc.
Sep 11, 2026
Exercise(M)
Direct
8K shares at avg. $12.50$100K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Sale(S)
Direct
1.3K shares at avg. $106.63$135K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Exercise(M)
Direct
8.5K shares at avg. $12.50$107K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Exercise(M)
Direct
1.5K shares at avg. $34.39$50K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Sale(S)
Direct
2.1K shares at avg. $104.67$220K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Sale(S)
Direct
2.1K shares at avg. $105.57$225K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Sale(S)
Direct
2.1K shares at avg. $107.71$231K
ORKA
Oruka Therapeutics, Inc.
Aug 13, 2026
Sale(S)
Direct
2.4K shares at avg. $108.46$256K
ORKA
Oruka Therapeutics, Inc.
Jul 13, 2026
Sale(S)
Direct
300 shares at avg. $83.07$25K
ORKA
Oruka Therapeutics, Inc.
Jul 13, 2026
Sale(S)
Direct
3.7K shares at avg. $84.26$315K
ORKA
Oruka Therapeutics, Inc.
Jul 13, 2026
Exercise(M)
Direct
1.5K shares at avg. $34.39$50K
ORKA
Oruka Therapeutics, Inc.
Jul 13, 2026
Exercise(M)
Direct
8.5K shares at avg. $12.50$107K

		Type	Shares	Price		Ownership
Oct 12, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	8,541	$12.50	$106,763	Direct
Oct 12, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	1,458	$34.39	$50,141	Direct
Oct 12, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	5,741	$80.03	$459,453	Direct
Oct 12, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,100	$80.76	$169,596	Direct
Oct 12, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	1,958	$81.86	$160,272	Direct
Oct 12, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	200	$82.83	$16,567	Direct
Sep 21, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	533	$95.75	$51,035	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	560	$95.71	$53,598	Direct
Sep 11, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	200	$94.02	$18,803	Direct
Sep 11, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,208	$93.26	$205,921	Direct
Sep 11, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	4,051	$92.41	$374,367	Direct
Sep 11, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	3,000	$91.11	$273,322	Direct
Sep 11, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	1,459	$34.39	$50,175	Direct
Sep 11, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	8,000	$12.50	$100,000	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	1,268	$106.63	$135,201	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	8,542	$12.50	$106,775	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	1,458	$34.39	$50,141	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,100	$104.67	$219,814	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,132	$105.57	$225,079	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,142	$107.71	$230,723	Direct
Aug 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,358	$108.46	$255,755	Direct
Jul 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	300	$83.07	$24,920	Direct
Jul 13, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	3,743	$84.26	$315,369	Direct
Jul 13, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	1,458	$34.39	$50,141	Direct
Jul 13, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	8,541	$12.50	$106,763	Direct

1-25 of 44 transactions

About Agarwal Arjun

Agarwal Arjun (SEC CIK 0002033974) files insider reports with the SEC as Senior Vice President, Finance of Oruka Therapeutics, Inc. (ORKA).

Signal8 holds 12 ownership filings by Agarwal Arjun (1 Form 3, 11 Form 4), filed between Sep 6, 2024 and Oct 13, 2026. Those filings report 44 transactions, from Jan 22, 2025 to Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Agarwal Arjun's filings is in MENLO PARK, CA.

Recent filings by Agarwal Arjun

Oct 12, 2026: Option exercises of ORKA shares (2 lines, Form 4, code M).
Oct 12, 2026: Open-market sales of ORKA shares (4 lines, Form 4, code S).
Sep 21, 2026: Open-market sale of ORKA shares (Form 4, code S).
Sep 15, 2026: Open-market sale of ORKA shares (Form 4, code S).
Sep 11, 2026: Open-market sales of ORKA shares (4 lines, Form 4, code S).

Other insiders filing for Oruka Therapeutics, Inc. (ORKA)

Klein Lawrence Otto, Chief Executive Officer
Quinlan Paul T, General Counsel
Goncalves Joana, Chief Medical Officer
Sandler Laura Lee, Chief Operating Officer
Edwards Larry Todd, Chief Commercial Officer
Fairmount Funds Management LLC, Director

How to read Form 4 transaction codes